Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000904454-26-000139
Filing Date
2026-02-27
Accepted
2026-02-27 16:42:52
Documents
1
Period of Report
2026-02-25

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 4031
  Complete submission text file 0000904454-26-000139.txt   5556
Mailing Address PAASHEUVELWEG 25A AMSTERDAM Netherlands 1105 BP
Business Address PAASHEUVELWEG 25A AMSTERDAM Netherlands 1105 BP 1-339-970-7000
uniQure N.V. (Issuer) CIK: 0001590560 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP
Business Address
KLEMT CHRISTIAN (Reporting) CIK: 0001711885 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36294 | Film No.: 26700986